Biblio

Export 3292 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
J. L. Cummings, Tong, G., and Ballard, C., “Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.”, J Alzheimers Dis, vol. 67, no. 3, pp. 779-794, 2019.
A. Subic, Cermakova, P., Religa, D., Han, S., von Euler, M., Kåreholt, I., Johnell, K., Fastbom, J., Bognandi, L., Winblad, B., Kramberger, M. G., Eriksdotter, M., and Garcia-Ptacek, S., “Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1119-1128, 2018.
S. D. Portbury, Hare, D. J., Sgambelloni, C., Perronnes, K., Portbury, A. J., Finkelstein, D. I., and Adlard, P. A., “Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 549-560, 2017.
T. Sao, Yoshino, Y., Yamazaki, K., Ozaki, Y., Mori, Y., Ochi, S., Yoshida, T., Mori, T., Iga, J. - I., and Ueno, S. - I., “TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1275-1284, 2018.
M. Stoiljkovic, Gutierrez, K. Otero, Kelley, C., Horvath, T. L., and Hajós, M., “TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-β-Related Hippocampal Pathophysiology in Mice.”, J Alzheimers Dis, 2021.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., “TREM2 variants in Alzheimer's disease.”, N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
M. A. Beydoun, Gamaldo, A. A., Beydoun, H. A., Shaked, D., Zonderman, A. B., and Eid, S. M., “Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.”, J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
R. Ravona-Springer, Schnaider-Beeri, M., and Goldbourt, U., “Triceps and Subscapular Skinfold in Men Aged 40-65 and Dementia Prevalence 36 Years Later.”, J Alzheimers Dis, vol. 57, no. 3, pp. 873-883, 2017.
W. Wu, Lee, I., Spratt, H., Fang, X., and Bao, X., “tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms.”, J Alzheimers Dis, vol. 79, no. 2, pp. 793-806, 2021.
M. Li, Liu, E., Zhou, Q., Li, S., Wang, X., Liu, Y., Wang, L., Sun, D., Ye, J., Gao, Y., Yang, X., Liu, J., Yang, Y., and Wang, J. - Z., “TRPC1 Null Exacerbates Memory Deficit and Apoptosis Induced by Amyloid-β.”, J Alzheimers Dis, vol. 63, no. 2, pp. 761-772, 2018.
I. Lejri, Grimm, A., Hallé, F., Abarghaz, M., Klein, C., Maitre, M., Schmitt, M., Bourguignon, J. - J., Mensah-Nyagan, A. Guy, Bihel, F., and Eckert, A., “TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1045-1058, 2019.
M. Sun, Zhao, Y., Han, M., Zhang, B., Zhang, X., Zhang, Q., Lim, N. K. - H., Wang, W. - A., and De Huang, F. -, “TTC7 and Hyccin Regulate Neuronal Aβ42 Accumulation and its Associated Neural Deficits in Aβ42-Expressing Drosophila.”, J Alzheimers Dis, vol. 65, no. 3, pp. 1001-1010, 2018.
C. Y. Liu, Ohki, Y., Tomita, T., Osawa, S., Reed, B. R., Jagust, W., Van Berlo, V., Jin, L. - W., Chui, H. C., Coppola, G., and Ringman, J. M., “Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1035-1041, 2017.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., “Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).”, J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
T. Rognoni, Fernández-Matarrubia, M., Martínez-González, M. Ángel, Salas-Salvadó, J., Corella, D., Castañer, O., J Martínez, A., Alonso-Gómez, Á. M., Gómez-Gracia, E., Vioque, J., Romaguera, D., López-Miranda, J., Estruch, R., Tinahones, F. J., Santos-Lozano, J. Manuel, Serra-Majem, L., Ibañez, N. Cano, Tur, J. A., Pérez, R. Micó, Pintó, X., Delgado-Rodríguez, M., Ramos, M. Ortiz, Martín, J. Vidal, Vázquez, C., Daimiel, L., Ros, E., Goñi-Ruiz, N., Babio, N., Sorlí, J. V., Schröder, H., García-Rios, A., Compañ-Gabucio, L., Warnberg, J., M Zulet, Á., Chaplin, A., Sacanella, E., Bouzalmate-Hajjaj, A., Tojal-Sierra, L., Damas-Fuentes, M., Vázquez, Z., Gómez-Martínez, C., Saiz, C., Malcampo, M., Ortiz-Morales, A. M., Martínez-Avilés, V., García-Gavilan, J., Abete, I., Fitó, M., and Toledo, E., “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
W. Li, Huang, E., and Gao, S., “Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review.”, J Alzheimers Dis, vol. 57, no. 1, pp. 29-36, 2017.
S. Davidson, Allenback, G., Decourt, B., and Sabbagh, M. N., “Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1573-1584, 2023.
U
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., “Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
M. Xie, Han, Y., Yu, Q., Wang, X., Wang, S., and Liao, X., “UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein.”, J Alzheimers Dis, vol. 49, no. 2, pp. 353-63, 2016.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N., “Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A., “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
N. Dermody, Wong, S., Ahmed, R., Piguet, O., Hodges, J. R., and Irish, M., “Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.”, J Alzheimers Dis, vol. 53, no. 3, pp. 801-16, 2016.

Pages